Volume Spike Investor

Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) shares are exploding 17% higher and September calls are trading more than 11,000 contracts with buyers in the $10’s and $12.50’s as shares cross $6.25.  Top line results for its Parkinson’s drug is expected by the end of Q3 for pimavanserin.  Update: as of 12:12 shares are up 17% and the volume is already twice normal at over 2 million shares vs. average volume of $925,000 shares.  52-week range is $0.72 to $6.40. 

-Joe Kunkle, OptionsHawk.com